Law360, New York (November 05, 2009, 6:47 PM ET) -- A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent.
In denying Abbott's post-trial bid to overturn the largest patent verdict in U.S. history, Judge T. John Ward of the U.S. District Court for the Eastern District of Texas ruled Wednesday that the drugmaker had failed to prove “by clear and convincing evidence that U.S. Patent Number 7,070,775...
$1.7B Centocor Patent Award Against Abbott Stands
To view the full article, take a free trial now.
